Anti-Infective Therapy is the infusion of antibiotic, antiviral, or antifungal drugs which are used to treat infections that do not respond to oral medications.
This report contains market size and forecasts of Anti-Infective Therapy in Global, including the following market information:
Global Anti-Infective Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-Infective Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Penicillin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Infective Therapy include Abbott Laboratories Ltd., Cipla Ltd., Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)), Glenmark Pharmaceuticals Limited, GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd), Lupin Limited, Panacea Biotec Limited, Novartis AG and Pfizer, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Infective Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Infective Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-Infective Therapy Market Segment Percentages, by Type, 2021 (%)
Penicillin
Sulphonamides
Aminoglycosides
Fluoroquinolones
Antifungals
Antiprotozoal
Others
Global Anti-Infective Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-Infective Therapy Market Segment Percentages, by Application, 2021 (%)
Home User
Hospitals/Clinics
Ambulatory Surgery Centres
Others
Global Anti-Infective Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-Infective Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Infective Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-Infective Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories Ltd.
Cipla Ltd.
Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
Glenmark Pharmaceuticals Limited
GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
Lupin Limited
Panacea Biotec Limited
Novartis AG
Pfizer, Inc.
Ranbaxy Laboratories Limited
Sun Pharmaceutical Industries Limited
AstraZeneca plc
Johnson & Johnson
WOCKHARDT
F. Hoffmann-La Roche Ltd
Sanofi
Merck